There are currently no known outstanding effects for the The National Health Service (Pharmaceutical Services) (Wales) Regulations 2013 (revoked), SCHEDULE 4.
Regulation 5
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Textual Amendments
F1Regulations revoked (1.10.2020 for the revocation of Pts. 1-3, 7, 8; 31.2.2021 for the revocation of regs. 8(1), 20; and 1.10.2021 in so far as not already in force) ) by The National Health Service (Pharmaceutical Services) (Wales) Regulations 2020 (S.I. 2020/1073), reg. 65 (with reg. 63)
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
